Social Anxiety disorder (also called Social Phobia; SAD) is the most common mental health condition which causes extreme fear in social settings, and an intense, persistent fear of being watched and judged by others. People with social anxiety disorder have trouble talking to people, meeting new people, attend social gatherings and can also affect day-to-day activities.
DelveInsight’s “Acute Social Anxiety Disorder Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Acute Social Anxiety Disorder, historical and forecasted epidemiology as well as the Acute Social Anxiety Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Download the report to know more about Acute Social Anxiety Disorder market trends @ Acute Social Anxiety Disorder market insight
Key highlights of Acute Social Anxiety Disorder market report are:
- The Acute Social Anxiety Disorder market size is anticipated to increase during the study period, 2019–2032.
- The increase in Acute Social Anxiety Disorder market size is a direct consequence of an increase in R&D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM.
- According to National Institute of Mental Health (NIMH), about 1 in 8 people (12.1%) experience social Anxiety Disorder at some time in their life and in a given year.
- As per Anxiety and Depression Association of America (ADAA) 2021, social anxiety disorder affects around 15 million adults, or 6.8% of US population.
- According to National Institute of Health and Care Excellence (NICE), the lifetime prevalence of Social Anxiety disorder is 12% in UK population.
- Key Acute Social Anxiety Disorder Companies working in the market are Vistagen Therapeutics, Bionomics and others.
- Emerging Acute Social Anxiety Disorder therapies fuelling the market are PH94B, BNC210 and others.
Key benefits of the Acute Social Anxiety Disorder Market report:
- Acute Social Anxiety Disorder market report covers a descriptive overview and comprehensive insight of the Acute Social Anxiety Disorder Epidemiology and Acute Social Anxiety Disorder market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Acute Social Anxiety Disorder market report provides insights on the current and emerging therapies.
- Acute Social Anxiety Disorder market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Acute Social Anxiety Disorder market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Acute Social Anxiety Disorder market.
Download the report to understand which factors are driving Acute Social Anxiety Disorder epidemiology trends @ Acute Social Anxiety Disorder Epidemiological Insights
Acute Social Anxiety Disorder Epidemiology
The Acute Social Anxiety Disorder epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The Acute Social Anxiety Disorder epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Acute Social Anxiety Disorder Epidemiology Segmentation:
The Acute Social Anxiety Disorder market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Acute Social Anxiety Disorder
- Prevalent Cases of Acute Social Anxiety Disorder by severity
- Gender-specific Prevalence of Acute Social Anxiety Disorder
- Diagnosed Cases of Acute Social Anxiety Disorder
Download free sample report to know more about recent developments in Acute Social Anxiety Disorder treatment market, visit @ Acute Social Anxiety Disorder Clinical Trials
Acute Social Anxiety Disorder Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Acute Social Anxiety Disorder market or expected to get launched during the study period. The analysis covers Acute Social Anxiety Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Acute Social Anxiety Disorder Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Discover more about therapies set to grab major Acute Social Anxiety Disorder market share @ Acute Social Anxiety Disorder market forecast
Scope of the Acute Social Anxiety Disorder Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Acute Social Anxiety Disorder Companies: Vistagen Therapeutics, Bionomics and others.
- Key Acute Social Anxiety Disorder Therapies: PH94B, BNC210 and others.
- Acute Social Anxiety Disorder Therapeutic Assessment: Acute Social Anxiety Disorder current marketed and Acute Social Anxiety Disorder emerging therapies
- Acute Social Anxiety Disorder Market Dynamics: Acute Social Anxiety Disorder market drivers and Acute Social Anxiety Disorder market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Acute Social Anxiety Disorder Unmet Needs, KOL’s views, Analyst’s views, Acute Social Anxiety Disorder Market Access and Reimbursement
Table of Contents
1. Acute Social Anxiety Disorder Market Report Introduction
2. Executive Summary for Acute Social Anxiety Disorder
3. SWOT analysis of Acute Social Anxiety Disorder
4. Acute Social Anxiety Disorder Patient Share (%) Overview at a Glance
5. Acute Social Anxiety Disorder Market Overview at a Glance
6. Acute Social Anxiety Disorder Disease Background and Overview
7. Acute Social Anxiety Disorder Epidemiology and Patient Population
8. Country-Specific Patient Population of Acute Social Anxiety Disorder
9. Acute Social Anxiety Disorder Current Treatment and Medical Practices
10. Acute Social Anxiety Disorder Unmet Needs
11. Acute Social Anxiety Disorder Emerging Therapies
12. Acute Social Anxiety Disorder Market Outlook
13. Country-Wise Acute Social Anxiety Disorder Market Analysis (2019–2032)
14. Acute Social Anxiety Disorder Market Access and Reimbursement of Therapies
15. Acute Social Anxiety Disorder Market Drivers
16. Acute Social Anxiety Disorder Market Barriers
17. Acute Social Anxiety Disorder Appendix
18. Acute Social Anxiety Disorder Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about Acute Social Anxiety Disorder treatment, visit @ Acute Social Anxiety Disorder Medications
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting